stars 1 stars 2 stars 3

The Immune Tolerance Network (ITN) is a collaborative network for clinical research, funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. Our mission is to accelerate the clinical development of immune tolerance therapies in asthma and allergy, autoimmune diseases, type 1 diabetes and solid organ transplantation. Immune tolerance therapies reprogram the immune system so that disease-causing immune responses are stopped while maintaining the immune system’s ability to combat pathogen infection. The ITN develops, funds and conducts clinical trials in conjunction with mechanistic, laboratory based studies.

Immune Tolerance Network Questions

The Immune Tolerance Network annual revenue was $89.5 million in 2026.

Vicki Seyfert-Margolis is the Chief Scientific Officer of Immune Tolerance Network.

14 people are employed at Immune Tolerance Network.

Immune Tolerance Network is based in Seattle, Washington.

The NAICS codes for Immune Tolerance Network are [6215, 62, 62151, 621].

The SIC codes for Immune Tolerance Network are [80, 807].

Top Immune Tolerance Network Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users